Evacetrapib

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameEvacetrapib
Drug Alias Nameevacetrapib依塞曲匹evacetrapibum依伐西曲匹LY-2484595
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHDL-cholesterol stimulantsCholesteryl ester transfer protein inhibitors
TargetsHDL-cholesterolCholesteryl ester transfer protein
Therapy Area/IndicationsHypercholesterolemiaHyperlipidemiasDyslipidemias +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBelgiumBulgaria +[38] 
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaDiscontinued
Originator CompaniesEli Lilly And Company
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEli Lilly And Company
Active IndicationsN/A
Inactive IndicationsHypercholesterolemiaHyperlipidemiasDyslipidemias +[5] 

Other Information

ATC CodeN/A
Related LinksWikipediaKEGG